|
|
||||||||
The Annals of Thoracic Surgery, Vol 54, 552-554, Copyright © 1992 by The Society of Thoracic Surgeons
N Brau, RA Esposito and MS Simberkoff
Major surgical procedures, especially when performed under general
anesthesia, can depress immunological parameters measured in vitro.
Therefore concern has been expressed that operation might have an adverse
effect on the immune status of individuals infected with the human
immunodeficiency virus (HIV). Four HIV-positive patients without symptoms
of HIV disease underwent cardiac valve replacement in consequence of
infective endocarditis. After up to 15 months postoperatively, 3 patients
are alive and well without signs of progressive immunodeficiency or
recurrent endocarditis. One patient died of recurrent endocarditis without
evidence of HIV-related disease on autopsy. Cardiac operation does not seem
to accelerate HIV-related immunodeficiency.
ARTICLES
Cardiac valve replacement in patients infected with the human immunodeficiency virus
Infectious Diseases Section, Department of Veterans Affairs Medical Center, New York, New York 10010.
This article has been cited by other articles:
![]() |
C.-A. Mestres, J. E. Chuquiure, X. Claramonte, J. Munoz, N. Benito, M. A. Castro, J. L. Pomar, J. M. Miro, and the Hospital Clinic Endocarditis Study Group Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1) Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 1007 - 1016. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |